Five Prime Therapeutics
FPRX
#5007
Rank
โ‚ฌ1.50 B
Marketcap
32,22ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Five Prime Therapeutics (FPRX)

Revenue in 2020 (TTM): โ‚ฌ15.29 Million

According to Five Prime Therapeutics's latest financial reports the company's current revenue is โ‚ฌ14.49 Million. In 2019 the company made a revenue of โ‚ฌ12.61 Million a decrease over the revenue in the year 2018 that were of โ‚ฌ42.28 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Five Prime Therapeutics from 2013 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ15.29 M21.22%
2019โ‚ฌ12.61 M-70.17%
2018โ‚ฌ42.28 M26.22%
2017โ‚ฌ33.5 M28.73%
2016โ‚ฌ26.02 M-91.92%
2015โ‚ฌ0.32 B1874.94%
2014โ‚ฌ16.3 M39.45%
2013โ‚ฌ11.69 M